Our Impact

UsAgainstAlzheimer’s was founded in 2010 to disrupt and diversify the movement to cure Alzheimer’s. Through urgent and inclusive mobilization, UsAgainstAlzheimer’s has worked to dramatically increase funding for Alzheimer’s and dementia research.

Share:

In partnership with many others, we have worked across sectors to

  • Secure almost one billion dollars in additional annual public funding for Alzheimer’s research, helping increase U.S. investment in dementia research at the National Institutes of Health from $448 million in 2010 to $1.8 billion for FY 2018 (a more than three-fold increase) and prompting the U.K., Canada, and Japan to commit to greater research investment.
  • Secure the national goal of preventing and effectively treating Alzheimer’s by 2025.
  • Drive global efforts that resulted in the G7 nations embracing a similar 2025 goal and calling for greater levels of research investment and collaboration.
  • Launch the Global Alzheimer’s Platform (GAP) Foundation to build the first global trial-ready platform for Alzheimer’s drug development--to reduce the time, cost and risk of getting innovative medicines to persons with or at risk of dementia.
  • Create LEAD Coalition (Leaders Engaged on Alzheimer’s Disease), the largest nationwide coalition of Alzheimer’s organizations. It is comprised of over 90 organizations with the ability to reach well more than 3 million individuals.
  • Launch the A-LIST, the first-ever patient and caregiver led industry coalition research network.
  • Convene CEO Initiative on Alzheimer’s (CEOi), bringing together the leading private-sector leaders to collaborate with government and researchers to overcome barriers to faster cures.
  • Drive U.S. and global action against dementia with the appointment of UsAgainstAlzheimer’s Chairman and Co-Founder George Vradenburg as a founding member of the U.S. Advisory Council on Alzheimer’s and of the World Dementia Council.
  • Help initiate the Dementia Friendly America initiative.
  • Lead the formation of the first-ever Global Alliance on Women’s Brain Health.
  • Raise public awareness through major news media: “Today” Show (NBC), NBC News, CNN, PBS, Associated Press, Wall Street Journal, USA Today, Washington Post, Boston Globe, Roll Call, The Hill, Huffington Post, Nature, Science, Scientific American, Psychology Today, and many more.

UsAgainstAlzheimer’s and our leadership have received numerous accolades and honors for our impact, from leading institutions such as the Alzheimer’s Drug Discovery Foundation, Research!America, and BrightFocus Foundation.

UsAgainstAlzheimer's Key Accomplishments

  • Drive global efforts that resulted in the G7 nations embracing a similar 2025 goal and calling for greater levels of research investment and collaboration.

     

     

  • Secure almost one billion dollars in additional annual public funding for Alzheimer’s research, helping increase U.S. investment in dementia research at the National Institutes of Health from $448 million in 2010 to $1.8 billion for FY 2018.

  • Launch the Global Alzheimer’s Platform (GAP) Foundation to build the first global trial-ready platform for Alzheimer’s drug development to reduce the time, cost and risk of getting innovative medicines to persons with or at risk of dementia.

  • Create LEAD Coalition (Leaders Engaged on Alzheimer’s Disease), the largest nationwide coalition of Alzheimer’s organizations. It is comprised of over 100 organizations with the ability to reach more than 3 million individuals.

 

Our_Impact

See what people are saying about UsAgainstAlzheimer's